Return to homepagePandemic Pact

UK Biobank SARS-CoV-2 Imaging Study

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-404

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    N/A

  • Funder

    UK Research and Innovation (UKRI)

  • Principal Investigator

    Rory Collins

  • Research Location

    United Kingdom

  • Lead Research Institution

    UK Biobank

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

UK Biobank will use the data from the home-test lateral flow devices (that identifies whether individuals have antibodies to SARS-CoV-2) to invite participants back for a repeat imaging scan. This repeat imaging study aims to include up to 1,500 participants who have positive antibodies and 1,500 who are negative to enable research into the effects of SARS-CoV-2 on internal pathophysiology (such as the heart, lungs, brain) by enabling research to compare MRI data before and after infection.